What types of clinical trial material issues can SSCI solve?
SSCI can help solve your most difficult solid-state problems. For example, improvement of properties when clinical data suggests the compound is not optimal. Additionally, when the solid form of a pharmaceutical company’s clinical trial material inadvertently varies from batch to batch, we can determine the properties of the different forms used, perform dissolution testing, recommend whether a bridging study needs to be carried out, and propose specific bridging study content. Finally, when a new polymorph appears during clinicals or after commercialization, we can analyze the solid form issues and assist in rapid reformulation or recommend effective process changes.
